HERO-UTUC: Intravesical RC48 After RNU for HER2+ UTUC
NCT07591805
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
49
Enrollment
OTHER
Sponsor class
Conditions
Upper Urinary Tract Urothelial Carcinoma
Interventions
DRUG:
Drug: Disitamab Vedotin
Sponsor
RenJi Hospital